These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 3553053

  • 41. The new quinolones and their combinations with other agents for therapy of severe infections.
    Desplaces N, Gutmann L, Carlet J, Guibert J, Acar JF.
    J Antimicrob Chemother; 1986 Mar; 17 Suppl A():25-39. PubMed ID: 3011726
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. The comparative activity of twelve 4-quinolone antimicrobials against Haemophilus influenzae and Streptococcus pneumoniae.
    Ridgway GL, O'Hare MD, Felmingham D, Grüneberg RN.
    Drugs Exp Clin Res; 1985 Mar; 11(4):259-62. PubMed ID: 2941258
    [Abstract] [Full Text] [Related]

  • 44. Comparative in vitro activity of seven quinolones against 100 clinical isolates of Clostridium difficile.
    Delmee M, Avesani V.
    Antimicrob Agents Chemother; 1986 Feb; 29(2):374-5. PubMed ID: 2940968
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Comparative in-vitro activity of Ro 23-6240, a new trifluorinated quinolone.
    Verbist L.
    J Antimicrob Chemother; 1987 Sep; 20(3):363-72. PubMed ID: 3119552
    [Abstract] [Full Text] [Related]

  • 47. Ciprofloxacin and norfloxacin, two fluoroquinolone antimicrobials.
    Nix DE, DeVito JM.
    Clin Pharm; 1987 Feb; 6(2):105-17. PubMed ID: 3311572
    [Abstract] [Full Text] [Related]

  • 48. A laboratory assessment of ciprofloxacin and comparable antimicrobial agents.
    Shrire L, Saunders J, Traynor R, Koornhof HJ.
    Eur J Clin Microbiol; 1984 Aug; 3(4):328-32. PubMed ID: 6237900
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Ofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Monk JP, Campoli-Richards DM.
    Drugs; 1987 Apr; 33(4):346-91. PubMed ID: 3297617
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. In-vitro selection of bacteria resistant to the 4-quinolone agents.
    Limb DI, Dabbs DJ, Spencer RC.
    J Antimicrob Chemother; 1987 Jan; 19(1):65-71. PubMed ID: 3470281
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. [In vitro and in vivo activities of norfloxacin, ofloxacin and ciprofloxacin against various mycobacteria].
    Saito H, Sato K, Tomioka H, Watanabe T.
    Kekkaku; 1987 May; 62(5):287-94. PubMed ID: 3114537
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Bacterial resistance to fluoroquinolones.
    Neu HC.
    Rev Infect Dis; 1988 May; 10 Suppl 1():S57-63. PubMed ID: 3279500
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.